The global vertebroplasty and kyphoplasty market will expand, according to a Transparency Market Research report.
Here are eight observations:
1. Complications with the traditional approach for treating vertebral compression fractures will drive the global vertebroplasty and kyphoplasty market.
2. The increasing geriatric population is boosting the prevalence of osteoporosis cases, which may lead to VCFs.
3. Vertebroplasty and kyphoplasty are intended to stabilize and relieve VCF-related pain.
4. The risk of another fracture and postoperative complications may hinder market growth, however.
5. The North American market saw the highest revenue generated from vertebroplasty and kyphoplasty devices. This is due to established healthcare infrastructure and patient compliance with the devices.
6. The European market is also strong, owing to healthcare technological advancements.
7. The Asia-Pacific market will grow at the highest compound annual growth rate due to opportunities in India and China.
8. Leading players in the market include DePuy Synthes, CareFusion Corp., Alphatec Spine, G-21 s.r.l., Medtronic, Stryker, Osseon, Taeyeon Medical Co., BMK Global Medical Company, Globus Medical and SOMATEX.